What Is Adjusted EBITDA? Here’s How The Largest Cannabis Companies Compare


Person Holding White and Blue BoxImage Source: Pexels
 What Is Adjusted EBITDA?EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, represents the cash profit generated by the company’s operations. Adjusted EBITDA figures remove non-recurring, irregular, and one-time items that may distort the EBITDA to make the resulting adjusted EBITDA more accurately and more easily comparable to the EBITDA of other companies in a given industry. According to Investopedia, common EBITDA adjustments include:

  • Unrealized gains or losses
  • Non-cash expenses (depreciation, amortization)
  • Litigation expenses
  • Gains or losses on foreign exchange
  • Goodwill impairments
  • Non-operating income
  • Share-based compensation
  • The adjusted EBITDA metric is very helpful when used in determining the value of a company when making a decision whether or not to invest. Please find below the Adj. EBITDA as a % of Net Revenue for the constituents in both the munKNEE’s Canadian Cannabis LPs Portfolio (designated with a *) and the American Cannabis MSOs Portfolio, in descending order, (the higher the adjusted EBITDA margin, the better) their latest quarterly financial reports (links provided) and their stock performances YTD as of today:
     Cannabis Company Adj. EBITDA as a % of Net Revenue Comparisons

  • Green Thumb (GTBIF): Adj. EBITDA of 35.7% of Net Revenue

  • Trulieve Cannabis (TCNNF): Adj. EBITDA of 35.5% of Net Revenue

  • Verano (VRNOF): Adj. EBITDA of 30.3% of Net Revenue

    • DOWN 11.8% YTD
  • Cresco Labs (CRLBF): Adj. EBITDA of 28.8% of Net Revenue 

  • Ayr Wellness (AYRWF): Adj. EBITDA of 24.7% of Net Revenue

  • Curaleaf (CURLF): Adj. EBITDA of 22.6% of Net Revenue

  • TerrAscend (TSNDF): Adj. EBITDA of 20.1% of Net Revenue 

    • DOWN 8,0% YTD
  • Tilray* (TLRY): Adj. EBITDA of 3.4% of Net Revenue

  • Aurora Cannabis* (ACB): Adj. EBITDA of 3.4% of Net Revenue 

  • OrganiGram* (OGI): Adj. EBITDA of (0.3)% of Net Revenue 

  • Canopy Growth* (CGC): Adj. EBITDA of (11.3)% of Net Revenue

  • Cronos* (CRON): Adj. EBITDA of (42.2)% of Net Revenue

  • More By This Author:These 17 AI Stocks Are The Sector’s Most Undervalued
    These 5 AI Stocks Are Reaching Sell Territory; Here’s Why
    All 12 Constituents In The Cannabis Portfolios Declined W/e May 24th

    Reviews

    • Total Score 0%
    User rating: 0.00% ( 0
    votes )



    Leave a Reply

    Your email address will not be published. Required fields are marked *